Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce that the company has received “study may proceed” clearance from the U.S. Food and Drug Administration to initiate ...

Veru Inc. (NASDAQ:VERU) Q1 2026 Earnings Call Transcript February 11, 2026 Veru Inc. beats earnings expectations. Reported EPS is $-0.26254, expectations were $-0.47. Operator: Good morning, ladies ...

As of Thursday, February 12, Viking Therapeutics, Inc.’s VKTX share price has surged by 13.80%, which has investors questioning if this is right time to sell.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2025 Earnings Call Transcript February 11, 2026 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS is $1.5 EPS, expectations were ...

The man likely never knew of the concealed penises, though he may have experienced pain surrounding sexual intercourse "due ...

Supraphysiologic anabolic steroid use is increasing among recreational athletes, causing cardiac, psychiatric, renal, and ...

As Neurocrine enters 2026, our foundation is stronger than at any point in our more than 30-year history and it continues to strengthen, with growing enterprise-wide momentum and strategic and ...

In the field of value-based medicine (VBM), the focus is increasingly shifting towards integrating innovative healthcare ...